JPS5692822A - Method of freeze drying live virus composition - Google Patents

Method of freeze drying live virus composition

Info

Publication number
JPS5692822A
JPS5692822A JP16974480A JP16974480A JPS5692822A JP S5692822 A JPS5692822 A JP S5692822A JP 16974480 A JP16974480 A JP 16974480A JP 16974480 A JP16974480 A JP 16974480A JP S5692822 A JPS5692822 A JP S5692822A
Authority
JP
Japan
Prior art keywords
freeze drying
live virus
virus composition
drying live
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP16974480A
Other languages
English (en)
Japanese (ja)
Inventor
Jiee Makuaree Uiriamu
Zetsuto Maakusu Henrii
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of JPS5692822A publication Critical patent/JPS5692822A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/165—Mumps or measles virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP16974480A 1979-12-03 1980-12-03 Method of freeze drying live virus composition Pending JPS5692822A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/099,772 US4273762A (en) 1979-12-03 1979-12-03 Lyophilization process for live viral compositions

Publications (1)

Publication Number Publication Date
JPS5692822A true JPS5692822A (en) 1981-07-27

Family

ID=22276548

Family Applications (1)

Application Number Title Priority Date Filing Date
JP16974480A Pending JPS5692822A (en) 1979-12-03 1980-12-03 Method of freeze drying live virus composition

Country Status (10)

Country Link
US (1) US4273762A (da)
EP (1) EP0030199B1 (da)
JP (1) JPS5692822A (da)
AT (1) ATE6201T1 (da)
CA (1) CA1146861A (da)
DE (1) DE3066651D1 (da)
DK (1) DK512780A (da)
ES (1) ES497361A0 (da)
GR (1) GR71638B (da)
PT (1) PT72105B (da)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02504312A (ja) * 1988-02-01 1990-12-06 クアドラント　バイオリソースイズ、リミテッド 高分子体の乾燥方法

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4337242A (en) * 1980-02-05 1982-06-29 Merck & Co., Inc. Vaccine stabilizer containing L-glutamic acid and L-arginine
US4338335A (en) * 1980-02-05 1982-07-06 Merck & Co., Inc. Vaccine stabilizer containing L-glutamic acid and L-arginine
US4537769A (en) * 1982-04-06 1985-08-27 American Cyanamid Company Stabilization of influenza virus vaccine
HU188847B (en) * 1983-02-22 1986-05-28 Human Oltoanyagtermeloe Es Kutato Intezet,Hu Process for producing liophylized combined vaccines
FR2561916B1 (fr) * 1984-03-30 1987-12-11 Lafon Labor Forme galenique pour administration orale et son procede de preparation par lyophilisation d'une emission huile dans eau
IL86180A (en) * 1987-05-04 1992-08-18 Merck & Co Inc Stable lyophilized live herpes virus vaccine and such a vaccine combined with other virus vaccines
US5024836A (en) * 1987-05-04 1991-06-18 Merck & Co., Inc. Stable lyophilized live herpes virus vaccine
US5169834A (en) * 1990-11-30 1992-12-08 American Cyanamid Company Compositions and method for reducing vial breakage during lyophilization
CZ289574B6 (cs) * 1992-06-04 2002-02-13 Merck And Co., Inc. Způsob výroby ľivé, atenuované vakcíny viru varicella zoster
US5360736A (en) * 1992-06-04 1994-11-01 Merck & Co., Inc. Process for attenuated varicella zoster virus vaccine production
DE122006000063I1 (de) 1992-07-17 2007-05-10 Merck & Co Inc Methode zur Verhinderung von Zoster und Linderung der mit Varicellea verbundenen Postherpetischen Neuralgie
CA2158935A1 (en) * 1993-10-12 1995-04-20 Chiron Viagene, Inc. Methods for preserving recombinant viruses
US5728386A (en) * 1993-12-21 1998-03-17 Merck & Co., Inc. Thermostable varicella zoster virus
JP2000507963A (ja) * 1996-12-20 2000-06-27 メルク エンド カンパニー インコーポレーテッド 凍結乾燥ワクチン用安定剤
US6290967B1 (en) * 1996-12-20 2001-09-18 Merck & Co., Inc. Stabilizers for lyophilized vaccines
US6051238A (en) * 1996-12-20 2000-04-18 Merck & Co., Inc. Stabilizers for lyophilized mumps vaccines
US6210683B1 (en) 1997-09-05 2001-04-03 Merck & Co., Inc. Stabilizers containing recombinant human serum albumin for live virus vaccines
US6465207B1 (en) 2000-11-03 2002-10-15 Cytologix Corporation Silver-based staining processes employing non-gelling gelatin
CA2549197C (en) * 2003-12-17 2015-04-14 Wyeth Methods for producing storage stable viruses and immunogenic compositions thereof
US20080294361A1 (en) * 2007-05-24 2008-11-27 Popp Shane M Intelligent execution system for the monitoring and execution of vaccine manufacturing

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3197374A (en) * 1962-10-11 1965-07-27 Behringwerke Ag Process for the disaggregation and purification of viruses
NL285236A (da) *
BE622212A (da) *
US3183161A (en) * 1955-05-02 1965-05-11 Parke Davis & Co Aqueous resuspension vaccine product of aluminum phosphate-adsorbed poliomyelitis virus antigen, and production process
US3078215A (en) * 1959-12-22 1963-02-19 Glaxo Group Ltd Process for the purification and concentration of poliomyelitis vaccine
GB960642A (en) * 1961-04-06 1964-06-10 Pfizer & Co C Measles vaccine
US3133861A (en) * 1961-11-08 1964-05-19 Dow Chemical Co Attenuated live measles virus vaccine and method of production
US3132073A (en) * 1962-03-14 1964-05-05 Lilly Co Eli Measles vaccine
US3478145A (en) * 1964-09-15 1969-11-11 American Home Prod Chromatographic purification of virus with brushite modified by autoclaving
US3316153A (en) * 1965-03-29 1967-04-25 Lilly Co Eli Virus purification
US3629399A (en) * 1967-09-05 1971-12-21 Behringwerke Ag Stable poliomyelitis vaccines
FR1604134A (da) * 1967-09-26 1971-07-12
US3509070A (en) * 1968-06-13 1970-04-28 American Home Prod Adsorbent for chromatographic purification of virus
US3555149A (en) * 1968-07-05 1971-01-12 Merck & Co Inc Mumps vaccine and its preparation
US3783098A (en) * 1971-08-10 1974-01-01 Cornell Res Foundation Inc Highly potent,viable and stable cellfree virus preparations from cells infected with cell-associated viruses and method for obtaining the same
US3933585A (en) * 1972-06-14 1976-01-20 Merck & Co., Inc. Process for production of vaccines
IL44143A0 (en) * 1973-02-07 1974-05-16 Wellcome Found Method of inactivating viruses and vaccines prepared thereby
US3915794A (en) * 1973-02-09 1975-10-28 Rit Rech Ind Therapeut Stabilizing compositions for cell-free viruses and cell-free virus preparations containing them
US3961046A (en) * 1974-12-02 1976-06-01 American Cyanamid Company Mumps vaccine and preparation thereof
US4147772A (en) * 1976-02-03 1979-04-03 Merck & Co., Inc. Vaccine stabilizer

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02504312A (ja) * 1988-02-01 1990-12-06 クアドラント　バイオリソースイズ、リミテッド 高分子体の乾燥方法

Also Published As

Publication number Publication date
ATE6201T1 (de) 1984-03-15
US4273762A (en) 1981-06-16
PT72105A (en) 1980-12-01
ES8205306A1 (es) 1982-06-01
GR71638B (da) 1980-11-29
PT72105B (en) 1982-06-25
ES497361A0 (es) 1982-06-01
DE3066651D1 (en) 1984-03-22
EP0030199A2 (en) 1981-06-10
CA1146861A (en) 1983-05-24
EP0030199B1 (en) 1984-02-15
DK512780A (da) 1981-06-04
EP0030199A3 (en) 1982-06-09

Similar Documents

Publication Publication Date Title
JPS5692822A (en) Method of freeze drying live virus composition
ES422961A1 (es) Procedimiento para preparar una suspension de virus.
ATE26115T1 (de) Substituierte 8-phenylxanthine.
AU4361879A (en) Inactivation of viruses
JPS56102786A (en) Preparation of concentrated virus group
AR223950A1 (es) Composicion insecticida sinergizada,que contiene como ingredientes activos(+)trans-crisantemato de(+-)2-alil-3-metil-ciclopent-2-en-1-on-4-ilo y (+)cis o(+)trans-crisantemato de n-(3,4,5,6-tetrahidroftalimido)-metilo
GB2037584B (en) Control of virus diseases in plants
NL174371C (nl) Rabiesvirus; uit dit virus bereid vaccin alsmede lokaas waarin dit vaccin is opgenomen.
CA961410A (en) Live attenuated infectious bovine rhinotracheitis virus vaccines and preparation thereof
IT1126819B (it) Antibiotici cefalosporinici,composizioni che li contengono e procedimento per produrli
ATE95427T1 (de) Gefriergetrockneter, stabiler, lebendiger herpesvirus-impfstoff.
GB1557668A (en) Virus insecticide compositions
IT1164746B (it) Antibiotici cefalosporinici,composizioni che li contengono e procedimento per produrli
IT8124347A0 (it) Emissioni di sostanze solide procedimento per ridurre le durante l'espulsione di una carica di coke da forni a camere orizzontali e camino per attuare il procedimento.
SE7805299L (sv) Virvelbeddsbrennkammare
SU570935A1 (ru) Схема питани фотоэлектронного приемника
AU4578879A (en) High efficiency combustion chamber
SU493127A1 (ru) Вирусный ингибитор
JPS53101593A (en) Preparation of antibiotics marthiomycin
GB879879A (en) Improvements in or relating to single cavity magnetrons
JPS5252381A (en) Power source
CA607992A (en) Stable poliomyelitis live virus vaccine
AU486934B2 (en) Live attenuated infectious bovine rhinotracheitis virus vaccines and preparation thereof
JPS5270722A (en) Photoelectric converter
JPS528558A (en) Sludge drying system to use heating medium